ArticleEuropean journal of medical research2025
Identification of a novel POU4F3 frameshift variant in a Chinese family with autosomal dominant hearing loss.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAutosomal dominant nonsyndromic hearing loss (ADNSHL) is characterised by highly clinical and genetic heterogeneity. A variant of POU4F3 is considered the pathogenic cause of ADNSHL, specifically designated as autosomal dominant nonsyndromic deafness 15 (DFNA15). The aim of this study was to explore the genetic variants and molecular pathogenic mechanism for a Chinese pedigree with DFNA15.
methodsA Chinese family with deafness underwent physical and otoscopic examinations, hearing measurements, and whole-exome sequencing. Sanger sequencing and segregation analysis were used to confirm the variants in the patients and healthy controls. The pathogenicity of the variants was detected using molecular modelling, immunoblotting and immunofluorescence experiments.
resultsThe patients showed bilateral, late-onset, progressive and sensorineural hearing loss without any other systemic diseases. Whole-exome and Sanger sequencing revealed a novel pathogenic variant, c.288dup, within the POU4F3 gene in the large Chinese family, which entirely cosegregated with the disease phenotype. The variant produced a truncated protein without functional domains, as determined using modelling, and theoretically destroyed the function of POU4F3. Immunofluorescence experiments revealed that the subcellular localisation of the mutant protein differed from that of wild-type protein, which could damage its normal function. In addition, immunoblotting experiments indicated that the mutant had lower protein expression than the wild type.
conclusionsWe first identified the frameshift variant (c.288dup, p.Ile97Hisfs*75) of POU4F3 associated with DFNA15. This study enriches the mutation spectrum of POU4F3 associated with hearing impairment and would help to illustrate the molecular pathogenic mechanism of POU4F3.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.